Linder N, Handsher R, Fruman O, Shiff E, Ohel G, Reichman B, Dagan R
Department of Pediatrics, Hadassah Medical Center, Jerusalem, Israel.
Pediatr Infect Dis J. 1994 Nov;13(11):959-62. doi: 10.1097/00006454-199411000-00005.
During the summer of 1988, an outbreak of poliomyelitis caused by poliovirus 1 occurred in Israel, during which a national mass immunization campaign with oral poliovirus was undertaken. This prospective study was undertaken to assess the effect of maternal oral poliovirus immunization during the third trimester of pregnancy on neonatal immunity against poliovirus. Cord blood specimens of 88 neonates, born 2 to 7 weeks after maternal immunization, were examined for antipoliovirus antibodies and compared with 100 samples obtained from neonates 7 months before the outbreak. Blood samples were also obtained from the 62 mothers of neonates who had been immunized 2 to 5 weeks before delivery. Sera were tested for neutralizing antibodies to the 3 poliovirus types using a microneutralization technique. The geometric mean titer to poliovirus type 1 was significantly higher in neonates whose mothers were immunized during pregnancy (87.1) than in the offspring of the nonvaccinated group (53.0), P < 0.05. Two to 3 weeks after immunization, geometric mean titers against all 3 poliovirus types were higher in maternal blood than in cord blood whereas 4 to 5 weeks after vaccination a significant difference was found for type 3 only. Although oral poliovirus immunization during pregnancy resulted in higher neonatal antibody titers to poliovirus type 1, the proportion of newborns with titers of < 1:8 to the 3 poliovirus types did not change significantly.
1988年夏天,以色列发生了由1型脊髓灰质炎病毒引起的脊髓灰质炎疫情,期间开展了全国口服脊髓灰质炎病毒大规模免疫运动。本前瞻性研究旨在评估孕期第三个月母体口服脊髓灰质炎病毒免疫对新生儿脊髓灰质炎病毒免疫的影响。对88名在母体免疫后2至7周出生的新生儿的脐带血样本进行抗脊髓灰质炎病毒抗体检测,并与疫情爆发前7个月从新生儿中获得的100份样本进行比较。还从62名在分娩前2至5周接受免疫的新生儿母亲那里采集了血样。使用微量中和技术检测血清中针对3种脊髓灰质炎病毒类型的中和抗体。母亲在孕期接受免疫的新生儿中,1型脊髓灰质炎病毒的几何平均滴度(87.1)显著高于未接种疫苗组的后代(53.0),P<0.05。免疫后2至3周,母体血液中针对所有3种脊髓灰质炎病毒类型的几何平均滴度高于脐带血,而接种疫苗后4至5周,仅在3型病毒上发现显著差异。尽管孕期口服脊髓灰质炎病毒免疫导致新生儿对1型脊髓灰质炎病毒的抗体滴度更高,但对3种脊髓灰质炎病毒类型滴度<1:8的新生儿比例没有显著变化。